Person: Dr David B. Shindler, CEO, Milestone Medica Corporation

Dr David B. Shindler

The Future is Now for Biomedical Research in Canada
By Dr David B. Shindler, CEO, Milestone Medica Corporation

Nearly 20 years ago, the National Biotechnology Advisory Committee (NBAC) reported to the federal government that Canada had serious limitations in its capability to commercialize biotechnology inventions.